Limited application of mometasone furoate on the face and intertriginous areas: analysis of safety and efficacy.
Lebwohl
M
M
Department of Dermatology, Mount Sinai Medical Center, New York, NY 10029-6574.
Peets
E
E
Chen
V
V
D000279:Administration, Cutaneous; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003876:Dermatitis, Atopic / Q000188:drug therapy*; D005148:Facial Dermatoses / Q000188:drug therapy*; D005500:Follow-Up Studies; D005938:Glucocorticoids; D006801:Humans; D007402:Intertrigo / Q000188:drug therapy*; D000068656:Mometasone Furoate; D009824:Ointments; D011244:Pregnadienediols / Q000008:administration & dosage / Q000627:therapeutic use*; D011565:Psoriasis / Q000188:drug therapy*; D012449:Safety; D013997:Time Factors
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D009824:Ointments; D011244:Pregnadienediols; D000068656:Mometasone Furoate